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Transcriptional coactivator PGC-1a integrates the
mammalian clock and energy metabolism
Chang Liu1, Siming Li1, Tiecheng Liu2, Jimo Borjigin2 & Jiandie D. Lin1
The mammalian clock regulates major aspects of energy metabol-
ism, including glucose and lipid homeostasis and mitochondrial
oxidative metabolism1,2. The biochemical basis for coordinated
control of the circadian clock and diverse metabolic pathways is
not well understood. Here we show that PGC-1a (Ppargc1a), a
transcriptional coactivator that regulates energy metabolism3–9,
is rhythmically expressed in the liver and skeletal muscle of mice.
PGC-1a stimulates the expression of clock genes, notably Bmal1
(Arntl) and Rev-erba (Nr1d1), through coactivation of the ROR
family of orphan nuclear receptors. Mice lacking PGC-1a show
abnormal diurnal rhythms of activity, body temperature and
metabolic rate. The disruption of physiological rhythms in these
animals is correlated with aberrant expression of clock genes
and those involved in energy metabolism. Analyses of PGC-1a-
deficient fibroblasts and mice with liver-specific knockdown of
PGC-1a indicate that it is required for cell-autonomous clock
function. We have thus identified PGC-1a as a key component
of the circadian oscillator that integrates the mammalian clock
and energy metabolism.
Most living organisms exhibit behavioural and physiological
rhythms, including activity, sleep, metabolism and body temperature.
These rhythms are controlled by a circadian clock and are subject to
regulation by light–dark cycles. In mammals, the central and peri-
pheral clocks are controlled by a common transcriptional circuitry
that generates rhythmic patterns of gene expression, most notably
those encoding metabolic enzymes10–14. Perturbations of circadian
rhythms have been associated with an increased risk for metabolic
disorders in humans15. Remarkably, mice with defective clock func-
tion develop obesity and have impaired glucose homeostasis16,17, sug-
gesting that the regulation of circadian clocks is linked to the pathways
of energy metabolism and potentially to the pathogenesis of metabolic
diseases. PGC-1a is an inducible transcriptional coactivator that reg-
ulates adaptive energy metabolism in multiple tissues4,6. The critical
role of this factor in linking the environment to metabolism prompted
us to examine whether PGC-1a regulates the circadian clock and
serves as a link between the clock and energy metabolism.
The clock oscillator consists of transcriptional activators and
repressors that are assembled into feedback loops18,19. To determine
the effects of PGC-1a on clock genes, we transduced primary hepa-
tocytes and C2C12 myotubes with recombinant adenoviruses expres-
sing green fluorescent protein (GFP) or PGC-1a. Quantitative PCR
(qPCR) analyses indicate that PGC-1a induces the expression of
Bmal1 and Clock in both cell types (Fig. 1a). Consistent with mes-
senger RNA expression, Bmal1 and Clock protein levels are elevated
in hepatocytes in response to PGC-1a (Fig. 1b). Clock and Bmal1 are
two basic helix–loop–helix transcription factors that activate the
transcription of period (Per) and cryptochrome (Cry) genes18,19.
Per and Cry proteins in turn inhibit their own expression by
repressing Clock/Bmal1 activity, forming the critical feedback loop
within the clock circuitry. Interestingly, the effects of PGC-1a on Per
and Cry gene expression seem to be cell-type-specific. Previous stud-
ies have implicated orphan nuclear receptors of the ROR and Rev-erb
families in the control of circadian clock function13,20–22. Although
PGC-1a exerts only modest effects on the expression of RORa (Rora)
and RORc (Rorc), it significantly induces Rev-erba and Rev-erbb
expression in both cell types (Fig. 1a).
Recent expression profiling studies have identified a large number
of genes that show rhythmic expression in the liver11–13. To assess the
role of PGC-1a in the regulation of circadian gene expression at the
transcriptome level, we performed microarray analysis on total RNA
isolated from primary hepatocytes transduced with GFP or PGC-1a
adenoviruses. We integrated the PGC-1a microarray data set with a
previously described set of 335 oscillating hepatic genes11 to deter-
mine global effects of PGC-1aon circadian genes. As shown in Fig. 1c,
47 of these circadian-regulated genes are induced by PGC-1a by more
than 1.8-fold, with the expression of many clustering at the onset and
during early dark phase (Supplementary Table 1). Analysis of PGC-
1a mRNA levels in mouse liver revealed a diurnal rhythm that peaks
at CT13 (CT0 is the onset at hour 0 of subjective light period),
gradually declines thereafter, and reaches a nadir at CT1 (Fig. 1d).
PGC-1a expression is similarly rhythmic in skeletal muscle, though
to a lesser degree. The expression of other PGC-1 coactivators, that is,
PGC-1b and PRC, also show circadian rhythms in these tissues.
Immunoblotting analyses indicate that PGC-1a protein reaches peak
levels in early dark phase (Fig. 1e), coinciding with the activation of
Bmal1 transcription and its mRNA accumulation. Interestingly, the
short isoform of PGC-1b shows a diurnal rhythm that peaks several
hours before PGC-1a. In contrast, the protein levels of Brm (also
known as Smarca2), a component of the SWI/SNF chromatin-
remodelling complexes, remain unchanged. Taken together, these
data indicate that rhythmic activation of PGC-1a, and possibly other
PGC-1 coactivators, may have an important role in the regulation of
clock function.
To identify transcription factors that mediate the regulation of
clock genes by PGC-1a, we examined the ability of PGC-1a to syner-
gize with these factors in the regulation of Bmal1 transcription. PGC-
1a dramatically augments the transcriptional activity of RORa and
RORc, but not C/EBPa, on a Bmal1 promoter reporter (Fig. 2a and
Supplementary Fig. 1). Coactivation of RORa by PGC-1a was prev-
iously observed for genes involved in muscle lipid metabolism23. In
contrast, PGC-1a exerts modest effects on the transcriptional activity
of Clock/Bmal1 (data not shown). The synergistic effects of ROR and
PGC-1a are abolished when the ROR-binding sites (RORE) on the
proximal Bmal1 promoter are mutated. Physical interaction assays
indicate that PGC-1a binds to RORa and RORc through the LXXLL
motifs (Supplementary Fig. 1). This functional synergy between
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RORa and PGC-1a is also observed for the endogenous Bmal1 gene
(Fig. 2b). Previous studies indicate that Rev-erba negatively regulates
Bmal1 transcription by recruiting corepressor proteins22, indicating
that the induction of Rev-erb factors may provide a negative feedback
mechanism for PGC-1a function. Consistent with this, both Rev-
erba and Rev-erbb drastically repress the stimulatory effects of
PGC-1a on the Bmal1-luc reporter (Fig. 2c). These results illustrate
that the ability of PGC-1a to activate Bmal1 transcription is modu-
lated by the relative abundance of the ROR and Rev-erb families of
orphan receptors.
Chromatin immunoprecipitation (ChIP) assays in HepG2 cells
indicate that PGC-1a is present near RORE on the proximal Bmal1
promoter (Fig. 2d). In addition, PGC-1a recruits histone acetyltrans-
ferases, including p300 and GCN5, but not Clock, a recently descri-
bed DNA-binding histone acetyltransferase24, to this site. Histone
hyperacetylation is associated with transcriptional activation. On
the other hand, trimethylation of lysine 4 of histone 3 (H3K4me3)
is a hallmark for actively transcribed genes, whereas H3K9 dimethyl-
ation (H3K9me2) is typically found in heterochromatin and silenced
genes25. Remarkably, PGC-1a expression leads to a robust increase in
histone H3 acetylation and H3K4me3 levels with a corresponding
reduction in H3K9me2 levels on the proximal Bmal1 promoter.
These results indicate that PGC-1a activates Bmal1 transcription
by altering the local chromatin environment from a repressive to
an active state.
The ability of PGC-1a to regulate the expression of clock genes
indicates that this factor may impact on the circadian clock, thereby
linking clock oscillators to energy metabolism. To test whether PGC-
1a is required for clock function in vivo, we monitored locomotor




























































































































































































Figure 1 | Regulation of clock genes by PGC-1a. a, qPCR analysis of clock
genes in primary hepatocytes and C2C12 myotubes. Shown is fold-induction
by PGC-1a. Data represent mean 6 s.d. *P , 0.02, PGC-1a versus GFP.
b, Immunoblots of hepatocyte lysates using the indicated antibodies. c, Effects
of PGC-1a on circadian-regulated genes in the liver. Fold induction by
PGC-1aof the circadian gene set was calculated on the basis of microarray data,
log-transformed and plotted against the respective peak timepoints of
expression in the liver (solid line, 1.8-fold). d, qPCR analysis of liver and skeletal
muscle gene expression. Data represent mean 6 s.d. *P , 0.01, peak versus











































































































































































Figure 2 | Regulation of Bmal1 gene transcription by PGC-1a and ROR.
a, Reporter gene assays using wild-type (Bmal1-luc) or RORE-mutant
(Bmal1DRORE-luc) Bmal1-luciferase reporters. *P , 0.01, PGC-1a versus
control. b, qPCR analysis of Bmal1 expression in transduced hepatocytes.
a, b, Error bars, s.d. *P , 0.05, RORa or PGC-1a versus Control; **P , 0.01,
RORa plus PGC-1a versus RORa. c, Reporter gene assays using Bmal1-luc
in the presence of Rev-erba or Rev-erbb. Shown with mean 6 s.d.
*P , 0.001, Rev-erb versus control. d, ChIP assay with the indicated
antibodies using HepG2 cells transduced with GFP or Flag–PGC-1a
adenoviruses. PCR primers amplify a fragment flanking the proximal RORE.
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using telemetry. Wild-type mice exhibit a free-running period of
approximately 23.7 h in constant darkness, whereas the free-running
period is approximately 24.0 h in PGC-1a null mice (Fig. 3a). In
addition, locomotor activity is evenly distributed throughout the
subjective night in the null mice. These results indicate that PGC-
1a regulates locomotor behaviour in mice and is required for
maintaining normal circadian periods. Diurnal oscillation of body
temperature is also distinct between these two genotypes (Fig. 3b).
Because PGC-1a is an important regulator of energy metabolism,
we next examined whether the daily oscillation of metabolic rate is
altered in the null mice. Using indirect calorimetry, we measured
oxygen consumption rate (VO2) in wild-type and PGC-1a null mice
over a period of three days6. Consistent with locomotor activity and
body temperature rhythms, VO2 is significantly higher in the dark
phase (Fig. 3c). Compared with wild-type mice, PGC-1a null mice
have elevated VO2 in both light and dark phases, though the diurnal
oscillation of VO2 is severely blunted. These results indicate that
PGC-1a is a critical component of the clock circuitry that may link
the clock oscillator to metabolism.
Analysis of clock gene expression indicates that the rise of Bmal1
mRNA levels is significantly impaired (37% lower at CT19), although
the rhythmic expression of Bmal1 is nearly intact in PGC-1a null
livers (Fig. 3d). In contrast, peak Bmal1 mRNA level is higher in
PGC-1a-deficient skeletal muscle (Fig. 3e), indicating that PGC-1a
deficiency differentially perturbs clock genes in different tissues.
Diurnal rhythms of Clock and Per1 mRNA are also disrupted in the
liver and skeletal muscle of PGC-1a null mice, respectively. We next
examine whether PGC-1a is required for the cyclic expression of
various enzymes involved in energy metabolism. PEPCK (PCK1), a
rate-limiting enzyme of hepatic gluconeogenesis, shows a daily cycle
that peaks at CT13 in the wild-type liver. PGC-1a seems to be dis-
pensable for the rhythmic expression of this enzyme. Nevertheless,
the mRNA levels of PEPCK are constitutively elevated at CT1 and
CT13 (Fig. 3d), in a similar way to the previous studies6. Pyruvate
dehydrogenase kinase 4 (PDK4) is a key regulator of the pyruvate
dehydrogenase complex that controls the flux of pyruvate into the
tricarboxylic acid cycle. The diurnal PDK4 expression is severely
impaired in PGC-1a-deficient liver and skeletal muscle, although
the phase of PDK4 oscillation seems to be preserved. Similarly, the
cyclic expression of fatty acid binding protein 3 (Fabp3/H-FABP) as
well as other mitochondrial genes involved in oxidative phosphory-
lation (OXPHOS), such as aconitase (Aco2) and Cox4a (Cox4i1), is
also disrupted in PGC-1a null skeletal muscle. Together, our results
illustrate that PGC-1a is essential for oscillatory expression of clock
and metabolic genes in vivo.
The defects in circadian rhythms of clock and metabolic gene
expression in PGC-1a null mice could potentially be affected by
altered central clock function. Previous work indicates that peri-
pheral oscillators can be reset by restricted feeding, essentially
uncoupling them from the master pacemaker in the suprachiasmatic
nucleus26. To determine whether PGC-1a is required for phase reset-
ting of peripheral clocks in response to feeding, we subjected wild-
type and null mice to night feeding and then switched them to day
feeding. Blood glucose concentrations show robust oscillation when
the mice were fed exclusively at night (Fig. 4a). The phase of glucose
oscillation is shifted by approximately 12 h after the feeding switch in
both groups. However, the amplitude of blood glucose rhythms is
significantly dampened in mice lacking PGC-1a. qPCR analyses
revealed that the expression of PGC-1a and clock genes are reversed
in response to restricted feeding in wild-type livers (Fig. 4b). In
contrast, feeding-induced resetting of clock gene expression is sig-
nificantly disrupted in PGC-1a null liver and skeletal muscle (Fig. 4b
and Supplementary Fig. 2). The expression of Bmal1 in the supra-
chiasmatic nucleus is also reduced in PGC-1a null mice (Sup-
plementary Fig. 2); however, the feeding switch does not seem to
alter Bmal1 expression patterns. Interestingly, PGC-1b mRNA levels
are elevated at some timepoints in these tissues.
To rule out the possibility that the perturbation of peripheral
clocks in PGC-1a null mice may be secondary to a compromised
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Figure 3 | Disruption of clock function in PGC-1a null mice. a, Locomotor
activity in wild-type and PGC-1a null mice under normal light:dark cycles
12:12 h (LD) or constant darkness (DD). Data were plotted in duplicate
columns in each panel. b, Representative traces of core body temperature in
wild-type and PGC-1a null mice. c, Metabolic rate in wild-type (filled square,
n 5 5) and PGC-1a null (open diamond, n 5 6) mice. Shown are average and
normalized VO2 during subjective night (N) and day (D). Error bars, s.e.m.
d, e, qPCR analysis of gene expression in pooled liver (d) and skeletal muscle
(e). Error bars, s.d. of the mean. *P , 0.05, wild-type (filled box) versus null
mice (open box).
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as well as in cultured cells. C57/Bl6J mice were transduced through
the tail vein with adenoviruses expressing random or short hairpin
RNA (shRNA) directed towards PGC-1a27. RNA interference (RNAi)
knockdown of PGC-1a in the liver significantly disrupts rhythmic
expression of Bmal1, Cry1 and Cry2 in this tissue, but not in the
suprachiasmatic nucleus (Fig. 4c and Supplementary Fig. 2). Serum
shock has been demonstrated to induce rhythmic clock gene express-
ion in cultured fibroblasts28. We exposed immortalized brown pre-
adipocytes to brief serum shock and analysed expression of clock
genes over a period of 36 h. Serum shock leads to robust oscillation
of Bmal1 and Rev-erba expression in wild-type cells (Fig. 4d). In
contrast, rhythmic expression of these genes is essentially abolished
in cells lacking PGC-1a. Consistent with these results, the ability of
RORa to induce the expression of Bmal1 and Rev-erba is impaired in
hepatocytes lacking PGC-1a (Supplementary Fig. 3), indicating that
PGC-1a is required for the transcriptional activity of RORa in this
context. We conclude from these studies that PGC-1a exerts its
effects on the circadian clock largely in a tissue- and cell-autonomous
manner.
We have identified PGC-1a, a major metabolic regulator, as a
critical component of the mammalian clock. PGC-1a stimulates
the expression of Bmal1 through coactivating the ROR family of
orphan nuclear receptors and is essential for normal circadian
rhythms. Because PGC-1a expression is highly responsive to nutri-
tional signals and potentially light, our findings support a mech-
anism through which energy metabolism and circadian clock can
be directly coupled at the transcriptional level (Fig. 4e). PGC-1a null
mice are resistant to diet-induced obesity and are more insulin-
sensitive6,17, whereas Clock mutant mice develop obesity. These dif-
ferences are probably due to the fact that PGC-1a null mice are
hyperactive and have a higher metabolic rate in the absence of
increased food intake. Our findings raise an intriguing possibility
that the expression and/or activity of PGC-1a itself may be regulated
by components of the clock oscillator. Because feeding and loco-
motor activity are regulated by circadian clocks, it is possible that
rhythmic PGC-1a expression is controlled by these physiological and
behavioural rhythms. Alternatively, PGC-1a is associated with the
SirT1 histone deacetylase complex29 and may directly sense the meta-
bolic state of the cell, in a similar way to the regulation of the clock
homologue NPAS2 by redox status30. Disruption of circadian
rhythms has been implicated in the pathogenesis of metabolic dis-
orders. Our studies have uncovered a potential molecular target
that could simultaneously modulate circadian clocks and energy
metabolism.
METHODS SUMMARY
Transcriptional analyses. Adenoviral transduction, reporter gene assays, and
ChIP experiments were performed as previously described 6,9. For gene express-
ion analyses, total RNA was isolated from tissues or cultured cells using Trizol
reagents (Invitrogen), reversed transcribed and analysed by quantitative PCR
using SYBR-Green.
Animal experiments. For activity and body temperature monitoring, wild-type
and PGC-1a null mice were implanted with a G2 Minimiter II probe in the
abdominal cavity (MiniMitter) and allowed to recover for two weeks prior to
the initiation of monitoring using telemetric receivers. Voluntary activity and
body temperature were recorded under light:dark cycles 12:12 h for two weeks
before switching to constant darkness for three more weeks. For restricted feed-
ing, male wild-type and PGC-1a null mice were fed exclusively at night for ten
days. Blood glucose levels were measured at the end of night feeding as well as
four days following the switch to day feeding. Tissues were harvested at CT1 and
13 for both feeding groups for qPCR analysis of gene expression. For liver-
specific PGC-1a knockdown, wild-type C57/Bl6J male mice were administered
control or PGC-1a RNAi adenoviruses via the tail vein. Tissues were harvested
from transduced animals five days after adenoviral transduction.
Serum shock. Immortalized fibroblasts from wild-type and PGC-1a null mice
were established and maintained in DMEM supplemented with 10% FBS. For
serum shock, media of confluent cultures was replaced with DMEM plus 50%
























































































































































































































































































































Figure 4 | Cell-autonomous role of PGC-1a in clock regulation. a, Plasma
glucose concentrations in wild-type (filled square, n 5 16) and PGC-1a null
mice (open diamond, n 5 14) subjected to night (NF) or day (DF) feeding.
Data were plotted in duplicate columns. b, qPCR analysis of total liver RNA
isolated from wild-type (filled box) and PGC-1a null (open box) mice.
c, qPCR analyses of hepatic gene expression in mice transduced with control
(filled box) or PGC-1a RNAi (open box) adenoviruses. Error bars in
a–c indicate s.e.m. a, b, c,*P , 0.05 wild-type versus null mice; **P , 0.01
NF versus DF. d, Time course expression of clock genes in wild-type (filled
circle) and PGC-1a null (open square) fibroblasts following serum shock.
Error bars, s.d. *P , 0.05 wild-type versus null cells. e, Model for
coordinated regulation of circadian clock and energy metabolism through
PGC-1a.
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incubated with serum-free DMEM. Total RNA was extracted at the indicated
time points and processed for qPCR analysis. More details are provided in
Methods.
Full Methods and any associated references are available in the online version of
the paper at www.nature.com/nature.
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METHODS
Adenoviral transduction. The maintenance and adenoviral transduction of
primary hepatocytes and C2C12 myotubes was performed, as previously
described6. Total RNA was isolated using Trizol reagents (Invitrogen) 48 h fol-
lowing transduction, reverse transcribed, and analysed by qPCR using SYBR
Green. A complete list of PCR primers is shown in Supplementary Table 2.
Primers for ribosomal protein 36B4 were included for normalization. Micro-
array analysis was performed on total RNA isolated from hepatocytes transduced
with GFP or PGC-1a adenoviruses using U74av2 chips (Affymetrix).
Animals. All animal procedures were approved by the University Committee on
Use and Care of Animals. For analysis of PGC-1a expression in tissues, male
C57/Bl6J mice of 12 weeks of age were kept under light:dark (LD) 12:12 h and
subsequently subjected to constant darkness for 36 h. Tissues from five mice were
dissected every 4 h for a total of 24 h thereafter. Total RNA was isolated and
analysed by qPCR using gene-specific primers. For analysis of gene expression in
wild-type and PGC-1a null mice, three to five mice of each genotype were
euthanized every six hours. Tissues were immediately frozen and subsequently
processed for qPCR analysis and immunoblotting analyses.
For activity and body temperature monitoring, 3-month old wild-type and
PGC-1a null mice were implanted with a G2 Minimiter II probe in abdominal
cavity (MiniMitter). Animals were allowed to recover for two weeks prior to the
initiation of monitoring using telemetric receivers. Voluntary activity and body
temperature were recorded under LD 12:12 h for two weeks before switching to
constant darkness for three more weeks. Data were analysed using software
supplied by the manufacturer. For restricted feeding, male wild-type and
PGC-1a null mice were fed exclusively at night for ten days. Blood glucose levels
were measured at the end of night feeding as well as four days following the
switch to day feeding. Tissues were harvested at CT1 and 13 for both feeding
groups for qPCR analysis of gene expression. For liver-specific PGC-1a knock-
down, a total of 32 C57/Bl6J male mice were administered control or PGC-1a
RNAi adenoviruses (0.1 absorbance units per mouse), as previously described.
Five days following tail vein injection, tissues were harvested from transduced
animals at CT1, 7, 13 and 19 (four mice per treatment).
Reporter gene assays. Reporter gene assays were performed in BOSC 293 cells, as
previously described. In a typical experiment, 25 ng of reporter plasmids were
mixed with 10 ng of expression constructs for transcription factors in the pres-
ence or absence of PGC-1a expression construct. Equal amounts of DNA were
used for all transfection combinations by adding appropriate vector DNA.
Relative luciferase activities were determined 48 h following transfection. All
transfection experiments were performed in triplicates.
Serum shock. Immortalized fibroblasts from wild-type and PGC-1a null mice
were established and maintained in DMEM supplemented with 10% FBS. For
serum shock, media of confluent cultures was replaced with DMEM plus 50%
horse serum (t 5 0), and after 1 h, the cells were washed once with PBS and
incubated with serum-free DMEM. Total RNA was extracted at the indicated
time points and processed for qPCR analysis using 36B4 as a normalization
control.
ChIP assay. Chromatin immunoprecipitation was performed essentially as
described by the Upstate Biotechnology (www.upstate.com). Briefly, HepG2
hepatoma cells were transduced with GFP or Flag–PGC-1a adenoviruses for
48 h. Chromatin lysates were prepared, pre-cleared with Protein-A agarose
beads, and immunoprecipitated with antibodies against Flag (Sigma), K9-
dimethylated and K4-trimethylated histone H3 (Abcam), acetylated histone
H3 (Upstate Biotechnology), p300 and Clock (Santa Cruz Biotech), GCN5
(BioLegend), or normal mouse IgG (Sigma) in the presence of BSA and salmon
sperm DNA. Beads were extensively washed before reverse cross-linking. DNA
was purified using a PCR purification kit (Qiagen) and subsequently analysed by
PCR using primers flanking the proximal RORE on the human Bmal1 promoter,
as detailed in Supplementary Table 2.
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